American Oriental Bioengineering, Inc. Stock Other OTC
Equities
AOBI
US0287315032
Pharmaceuticals
Financials (USD)
Sales 2011 | 213M | Sales 2012 | 145M | Capitalization | 13.35M |
---|---|---|---|---|---|
Net income 2011 | -67M | Net income 2012 | -59M | EV / Sales 2011 | 0.5 x |
Net Debt 2011 | 63.31M | Net Debt 2012 | 49.49M | EV / Sales 2012 | 0.43 x |
P/E ratio 2011 |
-0.62
x | P/E ratio 2012 |
-0.22
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 5.48% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Chun Li
FOU | Founder | 55 | - |
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shujun Liu
CEO | Chief Executive Officer | 71 | 70-11-29 |
Yan Chun Li
FOU | Founder | 55 | - |
1st Jan change | Capi. | |
---|---|---|
+25.98% | 653B | |
+27.00% | 556B | |
-6.48% | 354B | |
+20.15% | 331B | |
+3.98% | 296B | |
+13.00% | 233B | |
+5.59% | 201B | |
-9.61% | 193B | |
-6.31% | 144B |